世界の多嚢胞性卵巣症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Polycystic Ovary Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4692
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、127ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多嚢胞性卵巣症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（利尿剤、インスリン増感剤、抗アンドロゲン剤、抗うつ剤、オルニチンデカルボキシラ）、用途別市場規模（病院薬局、ドラッグストア、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多嚢胞性卵巣症候群の市場動向
・企業の競争状況、市場シェア
・多嚢胞性卵巣症候群の種類別市場規模（利尿剤、インスリン増感剤、抗アンドロゲン剤、抗うつ剤、オルニチンデカルボキシラ）
・多嚢胞性卵巣症候群の用途別市場規模（病院薬局、ドラッグストア、小売薬局）
・多嚢胞性卵巣症候群の北米市場規模2016-2027（アメリカ、カナダ）
・多嚢胞性卵巣症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多嚢胞性卵巣症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多嚢胞性卵巣症候群の中南米市場規模2016-2027（メキシコ、ブラジル）
・多嚢胞性卵巣症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Addex therapeutics、Himalaya、Astellas Pharma、AstraZeneca、Ava Science、Bayer、Bristol-Myers Squibb、Theralogix、Ferring Pharmaceuticals、Teva Pharmaceutical、GSK、Sneha Natura、Jarrow Formulas、Merck、Millendo Therapeutics、MyOva、Novartis、Ogeda、PCOS Diva、Pharmasure、Salveo Lifecare）
・結論

Market Analysis and Insights: Global Polycystic Ovary Syndrome Market
The global Polycystic Ovary Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Polycystic Ovary Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Polycystic Ovary Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Polycystic Ovary Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Polycystic Ovary Syndrome market.

Global Polycystic Ovary Syndrome Scope and Market Size
Polycystic Ovary Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polycystic Ovary Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diuretics
Insulin sensitizing agents
Antiandrogens
Anti-depressants
Ornithine decarboxylase inhibitors

Segment by Application
Hospital pharmacies
Drug stores
Retail pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Addex therapeutics
Himalaya
Astellas Pharma
AstraZeneca
Ava Science
Bayer
Bristol-Myers Squibb
Theralogix
Astellas Pharma
AstraZeneca
GSK
Sneha Natura
Jarrow Formulas
Merck
Millendo Therapeutics
MyOva
Novartis
Ogeda
PCOS Diva

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polycystic Ovary Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diuretics
1.2.3 Insulin sensitizing agents
1.2.4 Antiandrogens
1.2.5 Anti-depressants
1.2.6 Ornithine decarboxylase inhibitors
1.3 Market by Application
1.3.1 Global Polycystic Ovary Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital pharmacies
1.3.3 Drug stores
1.3.4 Retail pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Polycystic Ovary Syndrome Market Perspective (2016-2027)
2.2 Polycystic Ovary Syndrome Growth Trends by Regions
2.2.1 Polycystic Ovary Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Polycystic Ovary Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Polycystic Ovary Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Polycystic Ovary Syndrome Industry Dynamic
2.3.1 Polycystic Ovary Syndrome Market Trends
2.3.2 Polycystic Ovary Syndrome Market Drivers
2.3.3 Polycystic Ovary Syndrome Market Challenges
2.3.4 Polycystic Ovary Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Polycystic Ovary Syndrome Players by Revenue
3.1.1 Global Top Polycystic Ovary Syndrome Players by Revenue (2016-2021)
3.1.2 Global Polycystic Ovary Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Polycystic Ovary Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Polycystic Ovary Syndrome Revenue
3.4 Global Polycystic Ovary Syndrome Market Concentration Ratio
3.4.1 Global Polycystic Ovary Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polycystic Ovary Syndrome Revenue in 2020
3.5 Polycystic Ovary Syndrome Key Players Head office and Area Served
3.6 Key Players Polycystic Ovary Syndrome Product Solution and Service
3.7 Date of Enter into Polycystic Ovary Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Polycystic Ovary Syndrome Breakdown Data by Type
4.1 Global Polycystic Ovary Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Polycystic Ovary Syndrome Forecasted Market Size by Type (2022-2027)

5 Polycystic Ovary Syndrome Breakdown Data by Application
5.1 Global Polycystic Ovary Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Polycystic Ovary Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Polycystic Ovary Syndrome Market Size (2016-2027)
6.2 North America Polycystic Ovary Syndrome Market Size by Type
6.2.1 North America Polycystic Ovary Syndrome Market Size by Type (2016-2021)
6.2.2 North America Polycystic Ovary Syndrome Market Size by Type (2022-2027)
6.2.3 North America Polycystic Ovary Syndrome Market Size by Type (2016-2027)
6.3 North America Polycystic Ovary Syndrome Market Size by Application
6.3.1 North America Polycystic Ovary Syndrome Market Size by Application (2016-2021)
6.3.2 North America Polycystic Ovary Syndrome Market Size by Application (2022-2027)
6.3.3 North America Polycystic Ovary Syndrome Market Size by Application (2016-2027)
6.4 North America Polycystic Ovary Syndrome Market Size by Country
6.4.1 North America Polycystic Ovary Syndrome Market Size by Country (2016-2021)
6.4.2 North America Polycystic Ovary Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Polycystic Ovary Syndrome Market Size (2016-2027)
7.2 Europe Polycystic Ovary Syndrome Market Size by Type
7.2.1 Europe Polycystic Ovary Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Polycystic Ovary Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Polycystic Ovary Syndrome Market Size by Type (2016-2027)
7.3 Europe Polycystic Ovary Syndrome Market Size by Application
7.3.1 Europe Polycystic Ovary Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Polycystic Ovary Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Polycystic Ovary Syndrome Market Size by Application (2016-2027)
7.4 Europe Polycystic Ovary Syndrome Market Size by Country
7.4.1 Europe Polycystic Ovary Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Polycystic Ovary Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Polycystic Ovary Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Polycystic Ovary Syndrome Market Size by Type
8.2.1 Asia-Pacific Polycystic Ovary Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Polycystic Ovary Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Polycystic Ovary Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Polycystic Ovary Syndrome Market Size by Application
8.3.1 Asia-Pacific Polycystic Ovary Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Polycystic Ovary Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Polycystic Ovary Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Polycystic Ovary Syndrome Market Size by Region
8.4.1 Asia-Pacific Polycystic Ovary Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Polycystic Ovary Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Polycystic Ovary Syndrome Market Size (2016-2027)
9.2 Latin America Polycystic Ovary Syndrome Market Size by Type
9.2.1 Latin America Polycystic Ovary Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Polycystic Ovary Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Polycystic Ovary Syndrome Market Size by Type (2016-2027)
9.3 Latin America Polycystic Ovary Syndrome Market Size by Application
9.3.1 Latin America Polycystic Ovary Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Polycystic Ovary Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Polycystic Ovary Syndrome Market Size by Application (2016-2027)
9.4 Latin America Polycystic Ovary Syndrome Market Size by Country
9.4.1 Latin America Polycystic Ovary Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Polycystic Ovary Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Polycystic Ovary Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Polycystic Ovary Syndrome Market Size by Type
10.2.1 Middle East & Africa Polycystic Ovary Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Polycystic Ovary Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Polycystic Ovary Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Polycystic Ovary Syndrome Market Size by Application
10.3.1 Middle East & Africa Polycystic Ovary Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Polycystic Ovary Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Polycystic Ovary Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Polycystic Ovary Syndrome Market Size by Country
10.4.1 Middle East & Africa Polycystic Ovary Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Polycystic Ovary Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Polycystic Ovary Syndrome Introduction
11.1.4 Abbott Laboratories Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Addex therapeutics
11.2.1 Addex therapeutics Company Details
11.2.2 Addex therapeutics Business Overview
11.2.3 Addex therapeutics Polycystic Ovary Syndrome Introduction
11.2.4 Addex therapeutics Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.2.5 Addex therapeutics Recent Development
11.3 Himalaya
11.3.1 Himalaya Company Details
11.3.2 Himalaya Business Overview
11.3.3 Himalaya Polycystic Ovary Syndrome Introduction
11.3.4 Himalaya Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.3.5 Himalaya Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Polycystic Ovary Syndrome Introduction
11.4.4 Astellas Pharma Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Polycystic Ovary Syndrome Introduction
11.5.4 AstraZeneca Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Ava Science
11.6.1 Ava Science Company Details
11.6.2 Ava Science Business Overview
11.6.3 Ava Science Polycystic Ovary Syndrome Introduction
11.6.4 Ava Science Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.6.5 Ava Science Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Polycystic Ovary Syndrome Introduction
11.7.4 Bayer Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Polycystic Ovary Syndrome Introduction
11.8.4 Bristol-Myers Squibb Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Theralogix
11.9.1 Theralogix Company Details
11.9.2 Theralogix Business Overview
11.9.3 Theralogix Polycystic Ovary Syndrome Introduction
11.9.4 Theralogix Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.9.5 Theralogix Recent Development
11.10 Ferring Pharmaceuticals
11.10.1 Ferring Pharmaceuticals Company Details
11.10.2 Ferring Pharmaceuticals Business Overview
11.10.3 Ferring Pharmaceuticals Polycystic Ovary Syndrome Introduction
11.10.4 Ferring Pharmaceuticals Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.10.5 Ferring Pharmaceuticals Recent Development
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Details
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Polycystic Ovary Syndrome Introduction
11.11.4 Teva Pharmaceutical Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.11.5 Teva Pharmaceutical Recent Development
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Polycystic Ovary Syndrome Introduction
11.12.4 GSK Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.12.5 GSK Recent Development
11.13 Sneha Natura
11.13.1 Sneha Natura Company Details
11.13.2 Sneha Natura Business Overview
11.13.3 Sneha Natura Polycystic Ovary Syndrome Introduction
11.13.4 Sneha Natura Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.13.5 Sneha Natura Recent Development
11.14 Jarrow Formulas
11.14.1 Jarrow Formulas Company Details
11.14.2 Jarrow Formulas Business Overview
11.14.3 Jarrow Formulas Polycystic Ovary Syndrome Introduction
11.14.4 Jarrow Formulas Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.14.5 Jarrow Formulas Recent Development
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Polycystic Ovary Syndrome Introduction
11.15.4 Merck Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.15.5 Merck Recent Development
11.16 Millendo Therapeutics
11.16.1 Millendo Therapeutics Company Details
11.16.2 Millendo Therapeutics Business Overview
11.16.3 Millendo Therapeutics Polycystic Ovary Syndrome Introduction
11.16.4 Millendo Therapeutics Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.16.5 Millendo Therapeutics Recent Development
11.17 MyOva
11.17.1 MyOva Company Details
11.17.2 MyOva Business Overview
11.17.3 MyOva Polycystic Ovary Syndrome Introduction
11.17.4 MyOva Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.17.5 MyOva Recent Development
11.18 Novartis
11.18.1 Novartis Company Details
11.18.2 Novartis Business Overview
11.18.3 Novartis Polycystic Ovary Syndrome Introduction
11.18.4 Novartis Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.18.5 Novartis Recent Development
11.18 Ogeda
.1 Ogeda Company Details
.2 Ogeda Business Overview
.3 Ogeda Polycystic Ovary Syndrome Introduction
.4 Ogeda Revenue in Polycystic Ovary Syndrome Business (2016-2021)
.5 Ogeda Recent Development
11.20 PCOS Diva
11.20.1 PCOS Diva Company Details
11.20.2 PCOS Diva Business Overview
11.20.3 PCOS Diva Polycystic Ovary Syndrome Introduction
11.20.4 PCOS Diva Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.20.5 PCOS Diva Recent Development
11.21 Pharmasure
11.21.1 Pharmasure Company Details
11.21.2 Pharmasure Business Overview
11.21.3 Pharmasure Polycystic Ovary Syndrome Introduction
11.21.4 Pharmasure Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.21.5 Pharmasure Recent Development
11.22 Salveo Lifecare
11.22.1 Salveo Lifecare Company Details
11.22.2 Salveo Lifecare Business Overview
11.22.3 Salveo Lifecare Polycystic Ovary Syndrome Introduction
11.22.4 Salveo Lifecare Revenue in Polycystic Ovary Syndrome Business (2016-2021)
11.22.5 Salveo Lifecare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Polycystic Ovary Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diuretics
Table 3. Key Players of Insulin sensitizing agents
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Anti-depressants
Table 6. Key Players of Ornithine decarboxylase inhibitors
Table 7. Global Polycystic Ovary Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Polycystic Ovary Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Polycystic Ovary Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Polycystic Ovary Syndrome Market Share by Regions (2016-2021)
Table 11. Global Polycystic Ovary Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Polycystic Ovary Syndrome Market Share by Regions (2022-2027)
Table 13. Polycystic Ovary Syndrome Market Trends
Table 14. Polycystic Ovary Syndrome Market Drivers
Table 15. Polycystic Ovary Syndrome Market Challenges
Table 16. Polycystic Ovary Syndrome Market Restraints
Table 17. Global Polycystic Ovary Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Polycystic Ovary Syndrome Market Share by Players (2016-2021)
Table 19. Global Top Polycystic Ovary Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Ovary Syndrome as of 2020)
Table 20. Ranking of Global Top Polycystic Ovary Syndrome Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Polycystic Ovary Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Polycystic Ovary Syndrome Product Solution and Service
Table 24. Date of Enter into Polycystic Ovary Syndrome Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Polycystic Ovary Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Polycystic Ovary Syndrome Revenue Market Share by Type (2016-2021)
Table 28. Global Polycystic Ovary Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Polycystic Ovary Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Polycystic Ovary Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Polycystic Ovary Syndrome Revenue Market Share by Application (2016-2021)
Table 32. Global Polycystic Ovary Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Polycystic Ovary Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Polycystic Ovary Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Polycystic Ovary Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Polycystic Ovary Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Polycystic Ovary Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Polycystic Ovary Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Polycystic Ovary Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Polycystic Ovary Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Polycystic Ovary Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Polycystic Ovary Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Polycystic Ovary Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Polycystic Ovary Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Polycystic Ovary Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Polycystic Ovary Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Polycystic Ovary Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Polycystic Ovary Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Polycystic Ovary Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Polycystic Ovary Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Polycystic Ovary Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Polycystic Ovary Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Polycystic Ovary Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Polycystic Ovary Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Polycystic Ovary Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Polycystic Ovary Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Polycystic Ovary Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Polycystic Ovary Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Polycystic Ovary Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Polycystic Ovary Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Polycystic Ovary Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Polycystic Ovary Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Polycystic Ovary Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Polycystic Ovary Syndrome Product
Table 67. Abbott Laboratories Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Addex therapeutics Company Details
Table 70. Addex therapeutics Business Overview
Table 71. Addex therapeutics Polycystic Ovary Syndrome Product
Table 72. Addex therapeutics Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 73. Addex therapeutics Recent Development
Table 74. Himalaya Company Details
Table 75. Himalaya Business Overview
Table 76. Himalaya Polycystic Ovary Syndrome Product
Table 77. Himalaya Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 78. Himalaya Recent Development
Table 79. Astellas Pharma Company Details
Table 80. Astellas Pharma Business Overview
Table 81. Astellas Pharma Polycystic Ovary Syndrome Product
Table 82. Astellas Pharma Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 83. Astellas Pharma Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Polycystic Ovary Syndrome Product
Table 87. AstraZeneca Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Ava Science Company Details
Table 90. Ava Science Business Overview
Table 91. Ava Science Polycystic Ovary Syndrome Product
Table 92. Ava Science Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 93. Ava Science Recent Development
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Polycystic Ovary Syndrome Product
Table 97. Bayer Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 98. Bayer Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. Theralogix Company Details
Table 104. Theralogix Business Overview
Table 105. Theralogix Polycystic Ovary Syndrome Product
Table 106. Theralogix Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 107. Theralogix Recent Development
Table 108. Ferring Pharmaceuticals Company Details
Table 109. Ferring Pharmaceuticals Business Overview
Table 110. Ferring Pharmaceuticals Polycystic Ovary Syndrome Product
Table 111. Ferring Pharmaceuticals Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 112. Ferring Pharmaceuticals Recent Development
Table 113. Teva Pharmaceutical Company Details
Table 114. Teva Pharmaceutical Business Overview
Table 115. Teva Pharmaceutical Polycystic Ovary Syndrome Product
Table 116. Teva Pharmaceutical Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 117. Teva Pharmaceutical Recent Development
Table 118. GSK Company Details
Table 119. GSK Business Overview
Table 120. GSK Polycystic Ovary Syndrome Product
Table 121. GSK Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 122. GSK Recent Development
Table 123. Sneha Natura Company Details
Table 124. Sneha Natura Business Overview
Table 125. Sneha Natura Polycystic Ovary Syndrome Product
Table 126. Sneha Natura Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 127. Sneha Natura Recent Development
Table 128. Jarrow Formulas Company Details
Table 129. Jarrow Formulas Business Overview
Table 130. Jarrow Formulas Polycystic Ovary Syndrome Product
Table 131. Jarrow Formulas Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 132. Jarrow Formulas Recent Development
Table 133. Merck Company Details
Table 134. Merck Business Overview
Table 135. Merck Polycystic Ovary Syndrome Product
Table 136. Merck Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 137. Merck Recent Development
Table 138. Millendo Therapeutics Company Details
Table 139. Millendo Therapeutics Business Overview
Table 140. Millendo Therapeutics Polycystic Ovary Syndrome Product
Table 141. Millendo Therapeutics Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 142. Millendo Therapeutics Recent Development
Table 143. MyOva Company Details
Table 144. MyOva Business Overview
Table 145. MyOva Polycystic Ovary Syndrome Product
Table 146. MyOva Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 147. MyOva Recent Development
Table 148. Novartis Company Details
Table 149. Novartis Business Overview
Table 150. Novartis Polycystic Ovary Syndrome Product
Table 151. Novartis Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 152. Novartis Recent Development
Table 153. Ogeda Company Details
Table 154. Ogeda Business Overview
Table 155. Ogeda Polycystic Ovary Syndrome Product
Table 156. Ogeda Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 157. Ogeda Recent Development
Table 158. PCOS Diva Company Details
Table 159. PCOS Diva Business Overview
Table 160. PCOS Diva Polycystic Ovary Syndrome Product
Table 161. PCOS Diva Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 162. PCOS Diva Recent Development
Table 163. Pharmasure Company Details
Table 164. Pharmasure Business Overview
Table 165. Pharmasure Polycystic Ovary Syndrome Product
Table 166. Pharmasure Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 167. Pharmasure Recent Development
Table 168. Salveo Lifecare Company Details
Table 169. Salveo Lifecare Business Overview
Table 170. Salveo Lifecare Polycystic Ovary Syndrome Product
Table 171. Salveo Lifecare Revenue in Polycystic Ovary Syndrome Business (2016-2021) & (US$ Million)
Table 172. Salveo Lifecare Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polycystic Ovary Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Diuretics Features
Figure 3. Insulin sensitizing agents Features
Figure 4. Antiandrogens Features
Figure 5. Anti-depressants Features
Figure 6. Ornithine decarboxylase inhibitors Features
Figure 7. Global Polycystic Ovary Syndrome Market Share by Application: 2020 VS 2027
Figure 8. Hospital pharmacies Case Studies
Figure 9. Drug stores Case Studies
Figure 10. Retail pharmacies Case Studies
Figure 11. Polycystic Ovary Syndrome Report Years Considered
Figure 12. Global Polycystic Ovary Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Polycystic Ovary Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Polycystic Ovary Syndrome Market Share by Regions: 2020 VS 2027
Figure 15. Global Polycystic Ovary Syndrome Market Share by Regions (2022-2027)
Figure 16. Global Polycystic Ovary Syndrome Market Share by Players in 2020
Figure 17. Global Top Polycystic Ovary Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Ovary Syndrome as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Polycystic Ovary Syndrome Revenue in 2020
Figure 19. Global Polycystic Ovary Syndrome Revenue Market Share by Type (2016-2021)
Figure 20. Global Polycystic Ovary Syndrome Revenue Market Share by Type (2022-2027)
Figure 21. North America Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Polycystic Ovary Syndrome Market Share by Type (2016-2027)
Figure 23. North America Polycystic Ovary Syndrome Market Share by Application (2016-2027)
Figure 24. North America Polycystic Ovary Syndrome Market Share by Country (2016-2027)
Figure 25. United States Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Polycystic Ovary Syndrome Market Share by Type (2016-2027)
Figure 29. Europe Polycystic Ovary Syndrome Market Share by Application (2016-2027)
Figure 30. Europe Polycystic Ovary Syndrome Market Share by Country (2016-2027)
Figure 31. Germany Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Polycystic Ovary Syndrome Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Polycystic Ovary Syndrome Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Polycystic Ovary Syndrome Market Share by Region (2016-2027)
Figure 41. China Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Polycystic Ovary Syndrome Market Share by Type (2016-2027)
Figure 49. Latin America Polycystic Ovary Syndrome Market Share by Application (2016-2027)
Figure 50. Latin America Polycystic Ovary Syndrome Market Share by Country (2016-2027)
Figure 51. Mexico Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Polycystic Ovary Syndrome Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Polycystic Ovary Syndrome Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Polycystic Ovary Syndrome Market Share by Country (2016-2027)
Figure 57. Turkey Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Polycystic Ovary Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 61. Addex therapeutics Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 62. Himalaya Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 65. Ava Science Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 68. Theralogix Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 69. Ferring Pharmaceuticals Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 70. Teva Pharmaceutical Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 71. GSK Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 72. Sneha Natura Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 73. Jarrow Formulas Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 75. Millendo Therapeutics Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 76. MyOva Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 77. Novartis Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 78. Ogeda Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 79. PCOS Diva Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 80. Pharmasure Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 81. Salveo Lifecare Revenue Growth Rate in Polycystic Ovary Syndrome Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

以下、関連資料のご紹介

世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年）

Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4691 2021年4月 97Pages
QYResearch社発行の本調査資料では、多嚢胞性卵巣症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤＆SERM、利尿剤）、用途別市場規...

世界の多嚢胞性卵巣症候群（PCOS）治療市場規模・現状・予測（2021年-2027年）

Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4690 2021年4月 99Pages
QYResearch社発行の本調査資料では、多嚢胞性卵巣症候群（PCOS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口避妊薬、抗アンドロゲン剤、インスリン増感剤、抗うつ剤、抗肥満剤、その他）、用途別市場規模（卵巣楔状切除術、腹腔鏡下...

世界の多発性嚢胞腎治療市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4689 2021年4月 99Pages
QYResearch社発行の本調査資料では、多発性嚢胞腎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（診療所、研究センター、病院）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年）

Global Zollinger - Ellison Syndrome Testing Market Size, Status and Forecast 2021-2027
QYR2104Z6110 2021年4月 92Pages
QYResearch社発行の本調査資料では、ゾリンジャー-エリソン症候群検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成豚セクレチン、合成人間セクレチン）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z4515 2021年4月 99Pages
QYResearch社発行の本調査資料では、周期的発熱症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（高IgD症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）、用途別市場規模（病院、ドラッグス...

世界の腫瘍崩壊症候群市場規模・現状・予測（2021年-2027年）

Global Tumor Lysis Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z5758 2021年4月 92Pages
QYResearch社発行の本調査資料では、腫瘍崩壊症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アロプリノール、フェブキソスタット、ラスブリカーゼ、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメ...

世界のチャーグストラウス症候群市場規模・現状・予測（2021年-2027年）

Global Churg Strauss Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z1332 2021年4月 99Pages
QYResearch社発行の本調査資料では、チャーグストラウス症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）、用途別市場規模（研究所、病院、クリニック、その他）、主要地域別市場規模...

世界の脆弱X症候群遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Fragile X Syndrome Genetic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2456 2021年4月 97Pages
QYResearch社発行の本調査資料では、脆弱X症候群遺伝子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状前検査）、用途別市場規模（病院、クリニック、診断センター）、...

世界の吸収不良症候群市場規模・現状・予測（2021年-2027年）

Global Malabsorption Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z3532 2021年4月 90Pages
QYResearch社発行の本調査資料では、吸収不良症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（栄養補助食品、プロテアーゼ・リパーゼサプリメント、抗生物質、止瀉薬、抗炎症薬、その他）、用途別市場規模（製薬会社、病院、栄養クリニック、学...

世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年）

Global Dravet Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1961 2021年4月 92Pages
QYResearch社発行の本調査資料では、ドラベ症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））、用途別市場規模（病院薬局、小売薬局、Eコマース、その他）、主要...

世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
世界の多嚢胞性卵巣症候群（PCOS）治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels. The ovaries may develop numerous small collections of fluid (follicles) and fail to regularly r…
世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…
世界のバーター症候群治療市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
世界のクッシング症候群治療市場規模・現状・予測（2021年-2027年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…